Evidence map›Paper›PMID 39579261›Full record

ArticleNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2025

Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET.

Arianna Cappiello, Sofia Cuoco, Rosa De Micco, Sara Satolli, Francesca Di Biasio, Tiziana Benzi Markushi, Luisa Sambati, Andrea Pilotto, Matteo Costanzo, Chiara Longo and 13 more

Abstract read
PubMed Publisher
In one paragraph

Article in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Arianna CappielloCenter for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Sofia CuocoCenter for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Rosa De MiccoDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Sara SatolliMolecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione "Stella Maris", Pisa, Italy.
Francesca Di BiasioIRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy.
Tiziana Benzi MarkushiIRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy.
Luisa SambatiIstituto Delle Scienze Neurologiche Di Bologna, IRCCS, Bologna, Italy.
Andrea PilottoDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Matteo CostanzoDepartment of Neuroscience, Istituto Superiore Di Sanità, Viale Regina Elena 299, Rome, RM, Italy.
Chiara LongoDepartment of Neurology, Santa Chiara Hospital, Trento, Italy.
Tommaso SchirinziDepartment of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Eleonora Del PreteDepartment of Neuroscience, Neurology Unit, AOUP, Pisa, Italy.
Daniela FrosiniDepartment of Neuroscience, Neurology Unit, AOUP, Pisa, Italy.
Alessandro StefaniDepartment of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.
Maria Chiara MalagutiDepartment of Neurology, Santa Chiara Hospital, Trento, Italy.
Giovanni FabbriniDepartment of Human Neuroscience, Sapienza University of Rome, Viale Dell'Università 30, Rome, RM, Italy.
Alessandro PadovaniDepartment of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Giovanna Calandra-BuonauraIstituto Delle Scienze Neurologiche Di Bologna, IRCCS, Bologna, Italy.
Roberta MarcheseIRCCS Ospedale Policlinico San Martino Genoa, Genova, Italy.
Alessandro TessitoreDepartment of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy.
Paolo BaroneCenter for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy.
Marina PicilloCenter for Neurodegenerative Diseases (CEMAND), Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Salerno, Italy. mpicillo@unisa.it.ORCID http://orcid.org/0000-0001-9025-137X
P. S. P.-N. E. T. study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesNeuropsychiatric symptoms, such as apathy, disinhibition and irritability, are common in Progressive Supranuclear Palsy (PSP). The Frontal Behaviour Inventory (FBI) is a useful instrument for the evaluation of behavioural disorders in neurodegenerative diseases. The main goal of the present study was to explore the psychometric properties of the FBI in PSP. DESIGN, SETTING AND

participantsFBI was administered to the PSP-NET cohort including Italian patients diagnosed according to the Movement Disorder Society criteria. Patients underwent a clinical interview, a motor evaluation, extensive cognitive and behavioural testing.

resultsTwo hundred and eight subjects were included in this study. The internal consistency was high (Cronbach's alpha = 0.868) and no improvement of this value was noted upon removal of any item. FBI showed also good acceptability, reliability and validity. The standard error of measurement (SEM) value for FBI total score was 0.169 [SEM = SD √ (1 - Cronbach's alpha)]. Factor analysis indicated a five-factor structure: Apathy, Behavioural disorders, Impulsivity, Motor and speech frontal behaviour and Executive disorders that explained the 54.92% of the total variance. Linear regression analysis showed that global cognitive impairment significantly affects both Apathy and Motor and speech frontal behaviour factors.

conclusionsIn conclusion, FBI is a reliable and valid tool for the assessment of neuropsychiatric symptoms in PSP, despite some constructs, such as euphoria and irritability, are better measured by the NPI. Two third of the cohort was represented by Richardson's syndrome, thus our data are mainly applicable to such common phenotype. Such data are useful in both clinical and research settings to plan adequate therapeutic interventions and to improve the quality of life of PSP patients and their caregivers.

Indexed as

Behavioral SymptomsPsychometricsSupranuclear Palsy, ProgressiveAgedAged, 80 and overApathyCohort StudiesFemaleHumansMaleMiddle AgedNeuropsychological TestsReproducibility of ResultsMotor symptomsNeuropsychiatric symptomsProgressive supranuclear palsy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.